AKT1 and non-small cell lung carcinoma: Wang et al. found that CAMK2 inhibitor 1 (CAMK2N1) promoted autophagy and apoptosis through the Akt/mTOR pathway, effectively inhibiting invasion, migration, and angiogenesis in NSCLC.